The role of cytokines in cytokine release syndrome (CRS) after CAR T cell therapy
{{output}}
Chimeric antigen receptor (CAR) T cell therapy has transformed the treatment landscape for hematological malignancies. However, cytokine release syndrome (CRS) remains a common and potentially severe toxicity, significantly affecting patient safety and requiri... ...
